Detalhe da pesquisa
1.
BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer.
Oncogene
; 41(38): 4349-4360, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35948648
2.
Correction to: BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer.
Oncogene
; 42(8): 625, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36707621